NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed ...

Hart Howerton is excited to announce the firm's new leadership appointments for 2025. "We are proud to recognize a group of talented individuals whose growth as professionals and leaders has had a ...

NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...

Kinematics has gained P4Q’s expertise in full-stack electronics, including their market-leading tracker controls brand, Suntrack ®, to complement its innovative actuation systems. This acquisition ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

Q2 2025 Earnings Call February 4, 2025 8:00 AM ETCompany ParticipantsBen Krasinski - Senior Director, IRMichael J.

NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company ... will be satisfied with ...

the new BD will be a pure-play medical technology business. Focusing on research tools and sophisticated diagnostic solutions for infectious disease, cancer, and microbiology applications ...

Lactate Scout Vet is a Point-of-Care lactate analyzer designed for the needs of veterinarians and animal welfare professionals. The handheld Lactate Scout Vet requires only 0.2 µl of capillary ...